4 years, 11 months ago (2021-11-24 08:38)
2 Chinese anti-COVID-19 drug candidates enter human trials
Special: Battle Against Novel Coronavirus Two Chinese antiviral medicine for COVID-19 mainly developed by the Shanghai Institute of Materia Medica under the Chinese Academy of Sciences (CAS) have comm
...
Beware!
This is a preview of the article. To access the full text click on the source link or Sign In.